An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been scrambling to access their transdermal drug amid a nationwide shortage of the ...

Estrogen patches, one of the most common forms of hormone therapy for women, are becoming harder to find, and some ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

Women are finally demanding hormone therapy to treat menopause. Unfortunately, the system is not quite meeting the moment.

An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research context, pricing structure, and what to confirm before purchasing Wayne, NJ ...

The Food and Drug Administration is asking the public to weigh in on the merits of commercial drug-disposal products, for destroying leftover prescription opioids at home. The agency is considering ...

Women who can’t get the menopause hormone therapy they need after years of shortages are cutting patches in half, leaving ...

Experts weigh in on whether these stickers live up to the hype.

OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.

After 12 months of treatment, more 4- to 7-year-olds with peanut allergy using the Viaskin Peanut patch vs. placebo were deemed treatment responders, according to data presented here. Additionally, ...

Researchers from Nanjing Drum Tower Hospital, Southeast University, and Wenzhou Medical University have developed a novel microneedle patch that combines MXene hydrogel with nitric oxide (NO) and ...

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a dissolvable microneedle patch designed to deliver chemotherapy directly into ...